Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NAV
3676
DELISTED
Navistar International
NAV
| $446K | ﹤0.01% |
10,143
-1,626
| -14% | -$53.9K |
|
|
ONCE
3677
CALL
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $446K | ﹤0.01% |
+5,000
| New | +$380K |
|
|
RDC
3678
CALL
DELISTED
Rowan Companies Plc
RDC
| $446K | ﹤0.01% |
34,700
+26,800
| +339% | +$287K |
|
3679
PUT
Broadridge
BR
$18.8B
| $445K | ﹤0.01% |
5,500
+2,500
| +83% | +$193K |
|
3680
Innospec
IOSP
$2.25B
| $445K | ﹤0.01% |
7,216
+1,746
| +32% | +$105K |
|
3681
PUT
Brookfield Infrastructure Partners
BIP
$17.9B
| $444K | ﹤0.01% |
17,304
+13,272
| +329% | +$333K |
|
3682
PUT
Sony
SONY
$136B
| $444K | ﹤0.01% |
59,500
-10,500
| -15% | -$82.2K |
|
|
FRAN
3683
DELISTED
Francesca's Holdings Corporation
FRAN
| $444K | ﹤0.01% |
5,013
+602
| +14% | +$61K |
|
|
CBIO
3684
Crescent Biopharma
CBIO
$610M
| $443K | ﹤0.01% |
317
+40
| +14% | +$47K |
|
3685
PUT
Hartford Financial Services
HIG
$39.6B
| $443K | ﹤0.01% |
8,000
+6,800
| +567% | +$370K |
|
3686
State Street SPDR S&P Dividend ETF
SDY
$23.7B
| $443K | ﹤0.01% |
4,856
-3,764
| -44% | -$337K |
|
3687
CALL
Jefferies Financial Group
JEF
$13B
| $442K | ﹤0.01% |
19,550
+3,128
| +19% | +$70.1K |
|
3688
CALL
Keurig Dr Pepper
KDP
$41.3B
| $442K | ﹤0.01% |
5,000
+1,800
| +56% | +$163K |
|
3689
Teck Resources
TECK
$32.4B
| $442K | ﹤0.01% |
20,925
-220,700
| -91% | -$4.8M |
|
|
ATRS
3690
DELISTED
Antares Pharma, Inc.
ATRS
| $442K | ﹤0.01% |
136,338
+105,644
| +344% | +$326K |
|
|
TCF
3691
DELISTED
TCF Financial Corporation
TCF
| $441K | ﹤0.01% |
25,912
-2,871
| -10% | -$45.3K |
|
3692
iShares Gold Trust
IAU
$66B
| $440K | ﹤0.01% |
17,893
+3,200
| +22% | +$78.7K |
|
3693
MasTec
MTZ
$20.8B
| $440K | ﹤0.01% |
9,472
+8,231
| +663% | +$359K |
|
3694
PUT
ProShares Ultra Energy
DIG
$78.9M
| $439K | ﹤0.01% |
9,920
+8,320
| +520% | +$329K |
|
|
KTWO
3695
DELISTED
K2M Group Holdings, Inc
KTWO
| $439K | ﹤0.01% |
20,721
+13,290
| +179% | +$308K |
|
3696
Chemed
CHE
$7.18B
| $438K | ﹤0.01% |
2,169
-767
| -26% | -$151K |
|
3697
Old National Bancorp
ONB
$10.2B
| $438K | ﹤0.01% |
23,938
-20,665
| -46% | -$346K |
|
|
USCR
3698
DELISTED
U S Concrete, Inc.
USCR
| $438K | ﹤0.01% |
5,738
+38
| +0.7% | +$2.91K |
|
3699
CALL
Alkermes
ALKS
$8.11B
| $437K | ﹤0.01% |
8,600
+1,600
| +23% | +$85.6K |
|
3700
NorthWestern Energy
NWE
$4.32B
| $437K | ﹤0.01% |
7,682
+3,044
| +66% | +$182K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.